当期报告
诺瓦瓦克斯医药(NVAX)
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001000694-25-000031 Act: 34 Size: 311 KB 网页链接
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001000694-25-000031 Act: 34 Size: 311 KB 网页链接